Version-1
- Citation
- Abstract
- Reference
- Full PDF
| Paper Type | : | Research Paper |
| Title | : | Acute Spinal Cord Injury: Pharmacological Interventions |
| Country | : | India |
| Authors | : | Kumar Anshuman || Gourishankar Patnaik |
Abstract: Researchers are wary of giving people false hopes that a magic bullet for curing spinal cord injury is just around the corner. However, with accelerating progress in scientific research, there is renewed vitality and growing optimism that, with continued effort, the problems of spinal cord injury will be overcome. Although many years of intensive study have contributed to the development of the prostheses now being tested, they are really the first generation of useful devices. Better materials and enhanced technology can refine these devices to provide much better function. Rehabilitation techniques can greatly improve patients' health and quality of life by helping them learn to use their remaining abilities. Studies of problems that spinal cord injury patients experience, such as spasticity, muscle weakness, and impaired motor coordination, are leading to new strategies that may overcome these challenges. Overcoming spinal cord injuries will require general progress in many fields of neuroscience as well as specific studies in animal models of spinal cord injury and in patients themselves.
Keywords: spinal cord, regeneration, neural prosthesis
[1]. Spinal Cord Injury Information Network Online. Research for the Cure in Spinal Cord Injury: History of Cure Research. http://www.spinalcord.uab.edu/show.asp?durki=47987.
[2]. United Nations Population Division. Total world population report. Geneva: WHO 2009.
[3]. National Spinal Cord Injury Association. Report on injuries in the United States. Washington: NSCIA 2009.
[4]. International Campaign for Cures of Spinal Cord Injury Paralysis Online. General Information. http://www.campaignforcure.org/iccp/index.php?option=com_content&task=view&id=13&Itemid=28
[5]. Schwab ME, Bartholdi D. Degeneration and regeneration of axons in the lesion spinal cord. Physiology Review 1996; 76:319-370.
[6]. Raineteau O, Fouad K, Noth P, Thallmar M, Schwab ME. Functional switch between motor tracts in the presence of the mAb IN-1 in the adult rat. National Academy Science USA 2001; 98(n): 6929-6934.
[7]. Maisonpierre PC, Le Beau MM, Espinosa R 3rd, Ip NY, Belluscio L, de la Monte SM et al. Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations. Genomics 1991; 10(3): 558-68.
[8]. Delamater R B , Sherman J,Carr JB.(1995) Pathophysiology of spinal cord injury: Recovery after immediate and delayed decompression.JBJS(Am) 77 : 1042-1049
- Citation
- Abstract
- Reference
- Full PDF
| Paper Type | : | Research Paper |
| Title | : | Comparative Study of Efficacies of Timolol Maleate and Brimonidine Tartrate in Primary Open Angle Glaucoma Patients as Monotherapy |
| Country | : | India |
| Authors | : | Dr.Anitha N || Dr.Radhika Rani K.C || Dr.Ashalatha M |
Abstract: Background: Glaucoma is one of the important causes of blindness in India along with cataract, refractive errors and corneal opacities. The common denominator of all the glaucomas is a characteristic optic neuropathy which derives from risk factor including increased intra ocular pressure. Aim: The aim of the present study is to study the comparative efficacy of Timolol maleate (0.5%) and Brimonidine tartrate (0.2%) as monotherapy in human volunteers suffering from POAG for six months duration. Material And Methods: This was a prospective randomized comparative study. 25 Patients of POAG cases for Brimonidine treatment and 25 Patients of POAG cases for Timolol treatment are evaluated by using Tonometer opthalmoscope and visual field analyzer Results: Both Brimonidine and Timolo showed
[1]. Kingman, Sharon (2004) Glaucoma is second leading cause of blindness globally Bulliten of the World Health Organisation 82 (11) : 887-B
[2]. Schield's "Text book of Glaucoma", 5th Edition : Chapter 1 " Cellular and Molecular Biology of Aqueous Humor Dynamics"15-17
[3]. Bertram G. Katzung " Basic & clinical pharmacology" section II ; chapter 6 "Introduction to Autonomic Pharmacology". Pharmacology of eye : 91.
[4]. Geffrey D, Henderer and Christopher J. Rapuano.Goodman & Gilmans "The pharmacological Basis of Therapeutics" 1722- 1723
[5]. Lc Dutta, "Modern Ophthalmology", 3rd Edition, volume1-chapter 66 : Primary open angle glaucoma : Risk factors for Primary open angle glaucoma 480-482
[6]. Goodman & Gilmans "The pharmacological Basis of Therapeutics"11th edition; section XIV; Ophthalmology, chapter 63 "use of Autonomic Agents in the eye".1723
- Citation
- Abstract
- Reference
- Full PDF
| Paper Type | : | Research Paper |
| Title | : | Clinical Correlation of Copd Assessment Test (Cat) Questionnaire with Severity in Acute Exacerbation of Chronic Obstructive Pulmonary Disease |
| Country | : | India |
| Authors | : | Salma S || Yogitha C |
Abstract: Background: COPD is a disease that causes a lot of human suffering. The exacerbations of COPD add to the morbidity and mortality. The COPD assessment test(CAT) questionnaire is an eight item questionnaire that assesses the impact of COPD on the health status. We evaluated CAT score in a group of patients with acute exacerbation of COPD as a marker for COPD exacerbation and severe disease. Objectives: To assess usefulness ofCAT questionnaire as early markers for assessment of exacerbation risk and exacerbation severity.
1]. Halbert RJ, Natoli JL et al. Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006; 28:523-32.
[2]. Wedzicha JA, Seemungal TA. COPD exacerbations: defining their causeand prevention. Lancet 2007;370:786–796. [3]. Hurst J R, Vestbo J et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Eng J Med 2010; 363:1128-1138.
[4]. 4.WHO. World health statistics 2008.http :// www.who.int/whosis/whostat /EN WHS08 Full. pdf (accessed august 30, 2014)
[5]. Seemungal TA.Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161:1608-13.
[6]. 6.Alex J. Mackay, Gavin C. Donaldson et al. Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to Evaluate Severity of COPD Exacerbations. Am J RespirCrit Care Med 2012;Vol 185, Iss. 11, pp 1218–1224. [7]. 7.Jones, P. W., et al. "Development and first validation of the COPD Assessment Test." European Respiratory Journal 34.3 (2009): 648-654.
- Citation
- Abstract
- Reference
- Full PDF
| Paper Type | : | Research Paper |
| Title | : | Pattern of Skin Cancer -A Analytical Study |
| Country | : | India |
| Authors | : | Dr. H.U. Ghori || Dr Anupam Malviya || M. Sohaib || Dr P Hariadas |
Abstract: Incidence of skin cancers has been increasing since the last few decades worldwide. Non Melanoma Skin Cancer (NMSC) is the commonest variety of cutaneous malignancy. Basal cell carcinoma (BCC) and Squamous cell carcinoma (SCC), in combination, are referred to as Non melanoma skin cancers (NMSCs). This study was performed to understand the pattern of NMSCs in patients reported in the Department of Radiotherapy . The present study is a retrospective analysis of NMSC that presented to the Department of Radiotherapy Gandhi Medical College , from, Jan 2010to December 2013. . The patients were analyzed according to age, gender, site of involvement and histological types . During the 4 year study period, 17 cases were SCC and 9 cases were BCC. The most common age group for SCC was 40–50 years and BCC was 61–70 years. The most common site for SCC is lower limb followed by head neck ,while for BCC it is head and neck. For SCC, the most common histological type was well-differentiated and for BCC, it was the solid type. The importance of understanding the risk factors as well as studying the frequency of histo pathological patterns can help in the overall prognostic outlook for patients and also in planning an effective management
Keywords: Squamous cell carcinoma, Basal cell carcinoma, Non melanoma skin cancer
[1]. Preston DS, Stern RS. Nonmelanoma cancers of the skin. N Engl J Med. 1992;327:1649–62
[2]. National Cancer Registry Programme, Indian Council of Medical Research. Consolidated Report of the Population Based Cancer Registries. 1990-96
[3]. Leaf A. Potential health effects of global climatic and environmental changes. N Engl J Med. 1989;321:1577–83.
[4]. National Cancer Registry Programme, Indian Council of Medical Research (1990-1996) Consolidated Report of the Population Based Cancer Registries
[5]. Noorbala MT. Analysis of 15 years of skin cancer in central Iran (Yazd) Dermatol Online J. 2007;13(4):1